<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Karp, Jordan F.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">ADAPT</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-08-11 13:08:33</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-9</style></pages><abstract><style  face="normal" font="default" size="100%">This randomized trial was designed to compare the efficacy of venlafaxine with supportive management with venlafaxine with problem-solving therapy in older patients with comorbid chronic low back pain and depression. Although both treatment options improved pain and depression scores, problem-solving therapy provided no additional benefit.</style></abstract><number><style face="normal" font="default" size="100%">11</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>